Question 1

What is the catalog number for RNF139 CytoSection?

Accepted Answer

The catalog number for RNF139 CytoSection is TS409442P5.

Question 2

What sizes are available for RNF139 CytoSection?

Accepted Answer

RNF139 CytoSection is available in the following size(s): 25 Slides.

Question 3

Is RNF139 CytoSection in stock?

Accepted Answer

RNF139 CytoSection is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for RNF139 CytoSection?

Accepted Answer

The safety data sheet for RNF139 CytoSection is available here: https://cdn.origene.com/sds/ts409442p5.pdf.

Question 5

What is RNF139 CytoSection used for?

Accepted Answer

Transient overexpression of RNF139 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack

Question 6

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Question 7

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 8

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

RNF139 CytoSection

Product Specifications

Accession Number

Gene Location

Stability

Storage Conditions

Symbol

Frequently Asked Questions

Explore Other Products

Recombinant Ralstonia solanacearum Arginine--tRNA ligase (argS), partial

Fresolimumab

Fresolimumab

Fresolimumab

Fresolimumab

Fresolimumab